ResMed's net revenue rose 9.9% to $5.65B in fiscal 2026, and the company agreed to sell its MatrixCare business for $490 million in an all-cash transaction.

Filed August 13, 2026 · Period ending June 30, 2026 · Compared to 10-K Aug 8, 2025 · ~1 min read

Key Changes

• medium

  Net revenue increased 9.9% to $5.65B, with Sleep and Breathing Health revenue up 10.5% to $4.98B and Residential Care Software revenue up 5.4% to $675.8M.

  view on EDGAR →
• high

  Gross margin expanded to 61.1% from 59.4%, which the company attributes to procurement, manufacturing and logistics efficiencies, partially offset by expenses associated with a field safety notification for Astral devices.

  view on EDGAR →
• medium

  The company repurchased $700.0M of treasury stock, up from $300.0M a year earlier, and paid dividends of $349.7M.

  view on EDGAR →